Kling Bio partners with Sanofi
Kling Bio partners with Sanofi to discover novel, high-potency antibodies for combating viral diseases using its proprietary Kling-Select B cell platform.
Kling Bio partners with Sanofi to discover novel, high-potency antibodies for combating viral diseases using its proprietary Kling-Select B cell platform.
LR Health & Beauty appoints Jörg Körfer as new CEO. His focus will be on growth and operational excellence.
An AI-based MRI demonstrator identifies early brain changes typical of Alzheimer’s – an innovative tool for dementia research and diagnostics.
The new Biotech Report 2025 shows: Biopharmaceuticals dominate the market while precision medicine is transforming healthcare. Germany remains a hub for innovation.
The “Sexier than ever. Safer than before.” campaign by Zweisam and LIEBESLEBEN raises awareness about STIs for people 50+ – with confidence and clarity.
Zurich uses an AI-powered experiential campaign to spotlight the emotional impact of anosmia after Covid-19. A multisensory exhibition and scientific smell training offer hope to those affected.
medac and Clinigen expand their collaboration in the APAC region – six key therapies will be exclusively marketed and distributed.
Christian Schmitz has been appointed CEO of the Plan.Net Group and joins the executive board of the Serviceplan Group. He now leads two key players in AI-driven end-to-end models.
The next digital “Ask an Expert” Q&A session on the rare disease Polycythaemia Vera will take place on October 7, 2025. Patients can ask leading experts their personal questions.
The Future Health Index 2025 shows: AI has the potential to transform healthcare – but public trust is still lacking.